Endocrinology, Diabetes News | Endocrine Treatment & Research
网页A free diabetes, endocrinology and medical news article resource for endocrinologists and physicians. Endocrinology conference coverage and drug information.
The 2024 Update to the American Diabetes Association Standards …
网页2024年1月12日 · The American Diabetes Association (ADA) has updated its guidelines for the “Standards of Care” for patients with diabetes. The report has been published in Diabetes Care.. In the 2024 update, the ADA focused on patient-centered care, person-first language, and updated screening and treatment approaches based on …
Long-Term CGM System Eversense 365 Gets FDA Clearance
网页12 小时之前 · The Food and Drug Administration (FDA) has cleared the Eversense 365 continuous glucose monitoring (CGM) system for patients aged 18 years and older with type 1 or type 2 diabetes. Eversense ® 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes …
Type 2 Diabetes Mellitus - Endocrinology Advisor
网页4 天之前 · Type 2 diabetes mellitus is a metabolic disorder characterized by dysregulation of blood glucose caused by relative insulin deficiency and insulin resistance. 1 It is a progressive condition that have serious adverse effects on multiple organs and body functions, but it can be successfully managed with treatment that usually includes lifestyle ...
The 2023 Update to the American Diabetes Association’s …
网页2023年1月27日 · Note: The 2024 American Diabetes Association guideline summary is available here.. The American Diabetes Association (ADA) just published their yearly updated guidelines for the “Standards of Care in Diabetes” in Diabetes Care.. As new research and treatment options for patients with diabetes emerge, the standard of care for these patients continues to evolve.
Sedentary Behavior and CVD in Metabolic Dysfunction-Associated …
网页12 小时之前 · An association exists between leisure-time sedentary behavior and increased risk for cardiovascular disease (CVD) in metabolic dysfunction-associated fatty liver disease (MAFLD), although physical activity may alleviate the adverse effects, according to study findings published in Arteriosclerosis, Thrombosis, and Vascular Biology.. Investigators evaluated the association between leisure-time ...
Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
网页12 小时之前 · September 20, 2024. Lower diligence level linked to risk for new cardiovascular disease, but healthy lifestyle still beneficial. HealthDay News — Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 10 in BMJ Open Diabetes Research & Care.
How Do GLP-1 Receptor Agonists, Like Ozempic or Mounjaro, Work?
网页2024年6月14日 · GLP-1 receptor agonists also bind to the GLP-1 receptors on certain neurons in the brain to decrease hunger and increase satiety. They have been shown to slow gastric emptying within the first hour of eating, resulting in the feeling of being full. Patients who use GLP-1 receptor agonists experience reduced appetite and …
Diabetic Ketoacidosis (DKA) - Endocrinology Advisor
网页2024年4月2日 · Diabetic ketoacidosis (DKA) is an acute complication of diabetes that results from absolute or relative insulin deficiency. 1,2 It is characterized by the presence of metabolic acidosis, ketonemia, and hyperglycemia. 2 With prompt treatment, most patients with DKA recover, but in rare cases, such as patients who develop cerebral edema or have an underlying illness, DKA can become life ...
Improvements in Insulin Resistance With Semaglutide Primarily a …
网页2019年4月16日 · Treatment with semaglutide, a once-weekly glucagon-like peptide-1 (GLP-1) analog, consistently reduced body weight and insulin resistance in patients with type 2 diabetes, with improvements in insulin resistance being positively associated with weight loss, according to study results published in The Journal of …
跳至内容